Back to Search
CALVIN PILBEAM, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1588126940Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.
PMID 19404685·Support Care Cancer·2010
8-other
Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity.
PMID 19670271·J Cell Biochem·2009
7-preclinical
Effects of prostaglandin E2 on bone in mice in vivo.
PMID 19464663·Prostaglandins Other Lipid Mediat·2009
7-preclinical
Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice.
PMID 19344793·Bone·2009
7-preclinical
Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.
PMID 18834948·Prostaglandins Other Lipid Mediat·2009
7-preclinical
Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
PMID 18406186·Prostaglandins Other Lipid Mediat·2008
7-preclinical
Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.
PMID 18588457·Expert Rev Anticancer Ther·2008
6-review
Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
PMID 18501188·Biochem Biophys Res Commun·2008
7-preclinical
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
PMID 17650334·BMC Cancer·2007
7-preclinical
Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.
PMID 17467356·Bone·2007
7-preclinical
Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
PMID 17371157·J Bone Miner Res·2007
7-preclinical
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
PMID 16835407·Am J Physiol Renal Physiol·2006
7-preclinical
Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
PMID 16818639·Cancer Res·2006
8-other
Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
PMID 16514640·J Cell Biochem·2006
7-preclinical
Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts.
PMID 16476583·Biochem Biophys Res Commun·2006
7-preclinical
Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?
PMID 15625247·Endocrinology·2005
7-preclinical
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002.
PMID 16355502·J Bone Miner Res·2005
7-preclinical
Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes.
PMID 16303601·Prostaglandins Other Lipid Mediat·2005
7-preclinical
Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.
PMID 15619666·J Bone Miner Res·2005
7-preclinical
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells.
PMID 15660418·J Cell Biochem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5300 N MEADOWS DR
GROVE CITY, OH 43123 - Phone
- (614) 663-4550
Quick Facts
- NPI
- 1588126940
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile